Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Patch Pump Drug Delivery market size was valued at USD 116432.06 Million in 2022 and will reach USD 171269.13 Million in 2028, with a CAGR of 6.64% during 2022-2028.
Patch pumps are the convergence of several technologies into a single drug delivery device package. In doing so, this class of devices overcomes a number of shortcomings and limitations, while simplifying the drug administration event at the patient interface. Patch Pump Drug Delivery System does not have tubing, it is worn like a patch. Insulin pumps, such as Tandem slim X2TM and Animas® (Johnson & Johnson) insulin pump do not classify as patch pumps. Patch pumps have been around for years delivering insulin to diabetes patients with the promise of improving quality of life in managing their disease, but a number of devices have been designed and are being developed to be - within the limits of drug pharmacology - essentially API agnostic. There are however other drugs with treatment regimes that could benefit from the ease of use of a body-worn patch pump and it looks like that is starting to happen.
The growth of the patch pump drug delivery system market is largely driven by downstream
consumptions. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. With incidence rates climbing, medical device manufacturers are seeking solutions to help diabetes patients live active lives, especially for the millions of young people affected by the disease. Key advantage of drug delivery systems is that they allow the drug to target a specific site of action. This enables the drug's effect to be more localized and for sites to be targeted that would otherwise be difficult to reach. Drugs that are more site-specific can also help minimize undesired side effects. What is more, the technological advance, the entrance of international large enterprises, the growth of small businesses will also promote the patch pump drug delivery system market. However, side effects, the promulgation of relevant laws and regulations, especially in North America and Europe will affect the development of the industry to a certain extent. Alternatives are easy to get, such as pens, syringes, and injectors, they are much cheaper, user-friendly and reliable in our daily life. Other limitations include the device complexity, reimbursement constraints and high out-of-pocket-cost for patients.
Driving Factors
Improving living standards all over the world Growing population of diabetics world wide Smaller, more discrete and easier to use Patch Pump Drug Delivery System.
Market Restraints
Technology Concentrated Long product development cycle Each country's regulatory measures are more stringent Strict regulations from FDA and European countries.
Opportunities
Government Policy Support Human-friendly product development.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
The top three companies are Insulet Corporation, Medtronic, Valeritas, with the revenue market share of 39.76%, 14.58%, and 8.75% in 2016.
Segmentation Overview:
Among different product types, Electronic Delivery Devices segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Type 1 Diabetes segment occupied the biggest share from 2017 to 2022.
The Patch Pump Drug Delivery market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Patch Pump Drug Delivery market covered in Chapter 4:
Valeritas
Debiotech S.A.
EOFLOW CO., LTD.
Sensile Medical AG
Weibel CDS AG
Cellnovo Limited.
Medtronic
Amgen
CeQur SA.
ToucheMedical
Insulet Corporation
In Chapter 12 and Chapter 14.1, on the basis of types, the Patch Pump Drug Delivery market from 2018 to 2028 is primarily split into:
Mechanical Delivery Devices
Electronic Delivery Devices
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Patch Pump Drug Delivery market from 2018 to 2028 covers:
Type 1 Diabetes
Type 2 Diabetes
others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Patch Pump Drug Delivery market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Patch Pump Drug Delivery market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Patch Pump Drug Delivery industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Patch Pump Drug Delivery industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Patch Pump Drug Delivery market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Patch Pump Drug Delivery market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Patch Pump Drug Delivery market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Patch Pump Drug Delivery market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
2022
Patch pumps are the convergence of several technologies into a single drug delivery device package. In doing so, this class of devices overcomes a number of shortcomings and limitations, while simplifying the drug administration event at the patient interface. Patch Pump Drug Delivery System does not have tubing, it is worn like a patch. Insulin pumps, such as Tandem slim X2TM and Animas® (Johnson & Johnson) insulin pump do not classify as patch pumps. Patch pumps have been around for years delivering insulin to diabetes patients with the promise of improving quality of life in managing their disease, but a number of devices have been designed and are being developed to be - within the limits of drug pharmacology - essentially API agnostic. There are however other drugs with treatment regimes that could benefit from the ease of use of a body-worn patch pump and it looks like that is starting to happen.
The growth of the patch pump drug delivery system market is largely driven by downstream
consumptions. A longer life span is expected to translate to a growing number of patients diagnosed with chronic conditions. With incidence rates climbing, medical device manufacturers are seeking solutions to help diabetes patients live active lives, especially for the millions of young people affected by the disease. Key advantage of drug delivery systems is that they allow the drug to target a specific site of action. This enables the drug's effect to be more localized and for sites to be targeted that would otherwise be difficult to reach. Drugs that are more site-specific can also help minimize undesired side effects. What is more, the technological advance, the entrance of international large enterprises, the growth of small businesses will also promote the patch pump drug delivery system market. However, side effects, the promulgation of relevant laws and regulations, especially in North America and Europe will affect the development of the industry to a certain extent. Alternatives are easy to get, such as pens, syringes, and injectors, they are much cheaper, user-friendly and reliable in our daily life. Other limitations include the device complexity, reimbursement constraints and high out-of-pocket-cost for patients.
Driving Factors
Improving living standards all over the world Growing population of diabetics world wide Smaller, more discrete and easier to use Patch Pump Drug Delivery System.
Market Restraints
Technology Concentrated Long product development cycle Each country's regulatory measures are more stringent Strict regulations from FDA and European countries.
Opportunities
Government Policy Support Human-friendly product development.
Region Overview:
North America had the highest growth rate of all regions.
Company Overview:
The top three companies are Insulet Corporation, Medtronic, Valeritas, with the revenue market share of 39.76%, 14.58%, and 8.75% in 2016.
Segmentation Overview:
Among different product types, Electronic Delivery Devices segment is anticipated to contribute the largest market share in 2027.
Application Overview:
By application, the Type 1 Diabetes segment occupied the biggest share from 2017 to 2022.
The Patch Pump Drug Delivery market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Patch Pump Drug Delivery market covered in Chapter 4:
Valeritas
Debiotech S.A.
EOFLOW CO., LTD.
Sensile Medical AG
Weibel CDS AG
Cellnovo Limited.
Medtronic
Amgen
CeQur SA.
ToucheMedical
Insulet Corporation
In Chapter 12 and Chapter 14.1, on the basis of types, the Patch Pump Drug Delivery market from 2018 to 2028 is primarily split into:
Mechanical Delivery Devices
Electronic Delivery Devices
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Patch Pump Drug Delivery market from 2018 to 2028 covers:
Type 1 Diabetes
Type 2 Diabetes
others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Patch Pump Drug Delivery market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Patch Pump Drug Delivery market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Patch Pump Drug Delivery industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Patch Pump Drug Delivery industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Patch Pump Drug Delivery market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Patch Pump Drug Delivery market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Patch Pump Drug Delivery market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Patch Pump Drug Delivery market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
